GMAB

Genmab A/S

Price

$32.28

return (12m)

15.97% Logo

p/e

2.44

p/bv

0.35

DIVIDEND YIELD

0.00%
graph

GMAB price

Select period
Select period
Genmab
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.

Return on Investment GMAB

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
4.75%
3 months
27.87%
1 year
15.97%
2 years
17.53%
5 years
-26.68%
10 years
114.79%
Fundamental indicators

Fundamentals GMAB

Check the fundamentals of Genmab shares.

Valuation

P/E
2.44
Sector 10.54
Industry 53.57
P/BV
0.35
Sector 1.68
Industry 12.74
P/Revenue (PSR)
0.41
Sector 0.83
Industry 3.75
EV/EBITDA
12.57
Sector 19.03
Industry 64.66
EV/EBIT
13.38
Sector 21.50
Industry 66.41
P/EBITDA
1.64
Sector -6.84
Industry 58.39
P/EBIT
1.77
Sector -6.11
Industry 139.96
P/Total Assets
0.17
Sector 0.68
Industry 2.66
P/Net Current Assets
-0.55
Sector -4.07
Industry -9.87
P/Working Capital
1.25
Sector -4.84
Industry 364.13
EPS
13.87
Sector 0.95
Industry 36.75
BVPS
96.72
Sector 10.48
Industry 154.52

Efficiency

Gross Margin
92.98%
Sector 43.88%
Industry 50.77%
EBITDA Margin
21.01%
Sector 8.52%
Industry 40.96%
EBIT Margin
19.75%
Sector 4.39%
Industry 31.00%
Operating Margin
29.48%
Sector 5.14%
Industry 12.08%
Net Profit Margins
16.99%
Sector 2.00%
Industry 17.44%
Asset Turnover
0.16
Sector 0.21
Industry 0.20

Profitability

ROE
14.34%
Sector 3.56%
Industry 24.52%
ROA
6.82%
Sector 0.79%
Industry 12.35%
ROIC
16.02%
Sector -12.55%
Industry 2.37%

Dividends

Dividend yield
0.00%
Sector 0.29%
Industry 0.93%
Payout
0.00%
Sector 9.55%
Industry 23.26%

Debt

Current Ratio
2.46
Sector 1.04
Industry 1.36
Net Debt / EBITDA
7.74
Sector 0.54
Industry -5.91
Net Debt / EBIT
8.24
Sector 0.98
Industry -6.07
Net Debt / Equity
0.56
Sector -0.14
Industry -0.13
Gross Debt / Equity
0.81
Sector 0.19
Industry 0.21
Equity/Assets
0.48
Sector 0.31
Industry 0.57
Liabilities/Assets
0.52
Sector 0.63
Industry 0.85

Growth

5Y Revenue CAGR
11.26%
Sector -
Industry -
5Y Earnings CAGR
0.00%
Sector -
Industry -
Histórico de indicadores fundamentalistas

Fundamentals GMAB

RETORNO DO INVESTIMENTO

FAIR VALUE OF Genmab ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$32.28

Fair Value

$173.74

Upside Return potential.

438.30%
Because it considers equity value in its calculation, this formula may not work well for technology companies.
This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.
Buy And Hold Investor Checklist

Genmab Buy And Hold Investor Checklist

COMPARING GMAB WITH OTHER STOCK

graph

Stock vs Indice Comparison Tool

If you had invested
If you had invested
years ago
2 years
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.
Price

GMAB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT

Logo Genmab

Genmab A/S

Average Investor10 user rating

4.0 (9 people)

United States

United States

28 years

Founded: 1998

2019

Time since IPO - 7 years

781

Employees

Market cap

$2.08 billion

$2.08 billion

Net worth

$5.96 billion

$5,957,000,000.00

Assets

$12.52 billion

$12,515,000,000.00

Total Shares Outstanding

61.59 million

61,591,000

Average Daily Trading Volume

$-

$-

Shares

receitas e lucros

GMAB revenue and profits

graph

PROFIT X PRICE GMAB

Financials

Financial Results GMAB

DRAG THE FRAME TO SEE MORE DATA
Financials

GMAB cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - GMAB

Pontos Relevantes

GMAB balance sheet

DRAG THE FRAME TO SEE MORE DATA

Frequently Asked Questions

What is the price of Genmab (GMAB) today?

A cotação de Genmab (GMAB) hoje está em US$ 32.28, com uma variação de 15.97% em relação ao último ano. A cotação de Genmab (GMAB) iniciou o ano negociando na casa dos US$ 30.80 e hoje está em US$ 32.28. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Genmab (GMAB) e dados de ações do Ibovespa e mercados internacionais.

Quando Genmab (GMAB) paga dividendos?

Genmab (GMAB) não distribuiu dividendos no último ano.

Is Genmab (GMAB) a good investment?

Atualmente, Genmab (GMAB) está cotada a US$ 32.28, com um P/L de 2.44, representando um desvio de 405% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 15.97 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 15.97%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Genmab (GMAB) stock?

Investir em ações de Genmab (GMAB) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Genmab (GMAB) yield today?

A rentabilidade de Genmab (GMAB) foi de 4.75% no último mês, 15.97% no último ano e -26.68% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Genmab (GMAB) hoje, o investimento total seria de US$ 3,227.50, com base na cotação atual de US$ 32.28.

Based on historical performance, the investment would have grown to approximately:

  • Em 1 ano: US$ 3,742.93
  • Em 5 anos: US$ 2,366.40
  • Em 10 anos: US$ 6,932.35

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.